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Objectives: To describe the course of walking behaviour over 
a period of 1 year after stroke, using accelerometry, and to 
compare 1-year data with those from a healthy group.
Design: One-year follow-up cohort study.
Subjects: Twenty-three stroke patients and 20 age-matched 
healthy subjects.
Methods: Accelerometer assessments were made in the par-
ticipants’ daily environment for 8 h/day during the 1st (T1), 
12th (T2) and 48th (T3) weeks after stroke, and at one time-
point in healthy subjects. Primary outcomes were: percent-
age of time walking and upright (amount); mean duration 
and number of walking periods (distribution); step regular-
ity and gait symmetry (quality); and walking speed.
Results: Time walking, time upright, and number of walking 
bouts increased during T1 and T2 (p < 0.01) and then levelled 
off (p > 0.30). Mean duration of walking periods showed no 
significant improvements (p > 0.30) during all phases. Step 
regularity, gait symmetry and gait speed showed a tendency 
to increase consistently from T1 to T3. At T3, amount and 
distribution variables reached the level of the healthy group, 
but significant differences remained (p < 0.02) in step regu-
larity and gait speed.
Conclusion: In this cohort, different outcomes of walking 
behaviour showed different patterns and levels of recovery, 
which supports the multi-dimensional character of gait.
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INTRODUCTION
Stroke is associated with motor impairments that result in 
problems with walking. The International Classification of 
Functioning, Disability and Health (ICF) (1) offers a model 
to categorize these consequences of stroke into a range of 
domains, including “Body function and structures”, “Activ-
ity” and “Participation”. However, not all domains have been 
studied equally. Clinical studies focus mainly on testing func-
tion and structures, on gait characteristics, such as speed and 
spatiotemporal parameters measured in a controlled setting, 
which do not necessarily represent gait in daily life (2), and 
on activity and participation assessed with questionnaires (3). 
The consequences of stroke in daily life (the ICF perfor-
mance qualifier) have been studied relatively little. However, 
this type of study has become possible over recent decades 
through the use of portable devices, such as accelerometers 
(4–6). An example is the Vitaport Activity Monitor, which 
has the advantage of a high-resolution detection time of a 
large set of body postures and motions (including walking), 
and which can provide accurate and reliable data on quality 
parameters (7–10). 
Only a few studies have comprehensively and objectively 
examined walking behaviour (i.e. the performance of walk-
ing in a person’s daily life setting) among stroke patients (11, 
12). The long-term patterns and levels of recovery of walking 
performance are relatively unknown. 
Walking behaviour is an umbrella term involving several di-
mensions. Previous research has shown the potential relevance 
of 4 dimensions of walking behaviour: amount (6, 13); distribu-
tion (14–16); quality of gait (17, 18); and gait speed (19, 20). 
The amount of activities is an increasingly used parameter in 
studies of people with chronic conditions (6). However, there 
is growing evidence (14–16, 21) to support that it is not only 
the amount of a given activity that is important, but also how 
periods of activity are distributed in bouts of shorter or longer 
duration. Distribution has been studied for periods of physical 
activity, but also for sedentary behaviour, being an independ-
ent risk factor for chronic disease and poor health outcomes 
(22). The dimension gait quality (i.e. the way people walk) is 
a major issue in stroke rehabilitation (17, 18), as is gait speed, 
which has been shown to correlate with walking recovery after 
stroke (19, 20). 
The primary objective of this study is to assess the recovery 
of walking behaviour in terms of volume, distribution, qual-
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ity and gait speed over a period of 1 year following stroke. 
Secondary objectives were: to compare the patient data 1 
year after stroke with a healthy group, in order to assess the 
final state of recovery compared with healthy data; to explore 
the mutual relationships between the different domains of 
walking behaviour; and to assess the recovery of some other 
components of patients’ physical behaviour. Since walking 
and mobility are important goals in post-stroke recovery, 
monitoring these constructs might inform clinicians about the 
effectiveness of current interventions and therapy, or whether 
an improvement in mobility was achieved by a specific dose 
of intervention (5, 18, 23).
METHODS
Subjects
The source population for the present study were 50 patients included 
in the sit-to-stand stroke study of Janssen et al. (24), recruited from 
the stroke unit of the Erasmus Medical Centre (Rotterdam, The Neth-
erlands). Inclusion criteria were: (i) patients aged 20–90 years, and; 
(ii) who had had a stroke within the last 4 days. Exclusion criteria 
were: (i) comatose on day 4 post-stroke; (ii) previous stroke with 
persistent motor symptoms; (iii) current transient ischaemic attack; 
(iv) serious co-morbidity that interfered with walking; and (v) severe 
communication and cognitive impairment, as assessed by observing 
patients’ performance in response to movement instructions. All indi-
viduals provided written informed consent as approved by the ethics 
committee of the Erasmus Medical Center.
Healthy group data were collected from a database of 120 subjects’ 
measurements from previous studies at the Department of Physical 
Medicine and Rehabilitation of the Erasmus Medical Center. Prior 
written informed consent was provided to use the data for research 
purposes. A total of 20 healthy people, age-matched (± 4 years) to the 
stroke patients were included. 
Design and procedure
This prospective cohort study measured daily behaviour with an activ-
ity monitor (AM) during the 1st (T1), 12th (T2) and 48th (T3) weeks after 
stroke. Activity monitoring took place only if a patient was capable of 
independently performing a sit-to-stand movement. To be included in 
our sample subjects with stroke must have been measured with the AM 
for at least 2 of the 3 scheduled measurement times. For both stroke 
and healthy groups, the AM was worn in their daily environment from 
10.00 h to 18.00 h on weekdays.
Equipment
Accelerometric data were acquired with the Vitaport AM. Three piezo-
resistive (1.5 × 1.5 × 1 cm) accelerometers ADXL202 (Analog Devices, 
Breda, The Netherlands, adapted by Temec Instruments, Kerkrade, The 
Netherlands) were taped to the subject’s skin. One was attached to the 
sternum, with the sensitive axis oriented into the sagittal, longitudinal 
and transverse directions, and 1 to each thigh, with the sensitive axis 
oriented in the sagittal direction while standing (Fig. 1). Acceleration 
data were stored on a Vitaport 2 recorder (sample frequency 128 Hz), 
transferred to a PC and analysed with the Kinematic Analysis Module 
of the Vitaport Analysis Package. This program automatically detects 
a large set of body postures, motions and transitions between postures, 
with a 1-s resolution (Activity Detection Time Series). Postures and 
motions with a duration < 5 s were disregarded (25). The monitor 
stored raw data, so, from the recorded files, the time-frame analysed 
(from 10.00 h to 18.00 h) could be checked precisely. The reliability 
and validity of the AM for mobility detection has been studied ex-
tensively (7–10, 26).
Outcome measures and data analysis
Amount and distribution outcomes were derived from the Activity 
Detection Time Series with the Kinematic Analysis Module of the 
Vitaport Analysis Package, except for mean duration and number of 
walking bouts, which were calculated from the Activity Detection 
Time Series with custom-made Matlab programs. Quality and gait 
speed parameters were obtained from Matlab. For each dimension, 
we distinguished primary and secondary outcome parameters. Pri-
mary outcomes were selected on the key position of walking and gait 
(amount), on being most easily clinically interpretable (distribution), 
and on being most stable (quality).
Amount. All amount outcomes are expressed as a percentage of the 
measured period (8 h). The ability and accuracy of the AM to capture 
a large and specific set of postures and motions during daily life has 
been supported by different studies (7–10, 25, 26). Primary outcomes 
were: time walking and time upright (standing and walking). Second-
ary outcomes were: time sitting, time lying and sedentary time (lying 
and sitting).
Distribution. The distribution of activities was assessed by the method 
described by Chastin et al. (14, 15, 21), which quantifies the distribu-
tion of activities with respect to shorter or longer periods contributing 
to the total time of a given activity.
Primary outcomes were:
• Mean duration of walking bouts (mu). Mu is based on the mean 
value of walking bouts after log-normal transformation.
• Number of walking bouts.
Secondary outcomes were:
• Walking coefficient of variation, obtained after dividing mu by S2, 
the standard deviation of the log-normal distribution. 
• Sedentary exponent. A lower exponent indicates that subjects tend 
to accumulate sedentary time with a larger proportion of long sed-
entary bouts. Sedentary exponent was estimated using the robust 
maximum likelihood estimation technique (14).
Fig. 1. Study participant showing configuration of the activity monitor, 
with accelerometers on the sternum and thighs.
J Rehabil Med 47
716 M. Castel Sánchez et al.
Quality of walking. Gait quality parameters were calculated based 
on 10 walking periods throughout the 8-h AM measurement. At first, 
walking periods of at least 20 s, automatically determined by a custom-
made software program, were selected for analysis. Then, within 
these periods, an interval of “stable” walking was chosen manually. 
The samples related to the first and the last 2 steps were excluded to 
avoid transitional phases of gait initiation and termination. All quality 
outcomes, except for step-time ratio, were computed on the basis of 
the unbiased autocorrelation coefficients for trunk acceleration during 
walking, according to Moe-Nilssen & Helbostad (27).
The primary outcomes were:
• Step regularity derived from the longitudinal trunk sensor, LAd1 
(Longitudinal Autocorrelation coefficient at 1st Dominant period). 
LAd1 close to 1.0 reflects high step regularity. 
• Gait symmetry (LAd1/LAd2) derived from the longitudinal accel-
eration signal. Closeness to 1.0 reflects symmetrical gait.
Secondary outcomes were: 
• Stride regularity for the longitudinal and transverse directions (LAd2 
and TAd2). An Ad2 (Autocorrelation coefficient at 2nd dominant 
period) close to 1.0 reflects high stride regularity.
• Step regularity (TAd1) and gait symmetry (TAd1/TAd2) based on 
the transversal acceleration signal.
• Step-time ratio. Based on the detection of heel contacts from the thigh 
sensors signals. The ratio was expressed as paretic step-time divided 
by non-paretic step-time (stroke group), and as right step-time divided 
by left step-time (healthy group). Closeness to 1 reflects symmetry. 
Gait speed. Stroke patients’ gait speed was obtained from a 5-m 
walking test. For both healthy and stroke subjects an indicator of gait 
speed was calculated from the acceleration signals: body motility dur-
ing walking. Previous research (28, 29) has shown that this measure 
correlates well (R = 0.88 and 0.90) (28) with gait speed. 
Statistical analysis
Statistical analyses were performed using SPSS for Windows (version 
17.0). The match between patients and control subjects was checked 
via independent-samples t-tests and χ2 tests. First, descriptive statistics 
were generated. Secondly, analysis of longitudinal change was per-
formed for each outcome using linear mixed model (LMM) analysis, 
taking into account correlations of measurements within and between 
patients. Through estimating the covariance structure, this method 
is very flexible in handling missing data. Time of measurement was 
entered as a factor in each model in order to evaluate change over the 
total follow-up period (T1, T2, T3) and to compare changes between 
the individual time-points in post-hoc analyses (T1–T2, T2–T3, and 
T1–T3). To check the effect of multiple testing, Bonferroni corrections 
were also applied in the post-hoc analyses. The models were adjusted for 
subject’s incapability to rise independently from the chair at T1 in the 
LMM. Independent-samples t-tests were used to compare data between 
healthy and stroke groups. Finally, a correlation analysis (Pearson) was 
conducted to examine relationships between different domains of gait.
For all statistical analyses p < 0.05 was considered statistically 
significant.
RESULTS
A total of 50 stroke patients was enrolled initially. Eight per-
sons withdrew from the study after inclusion, 9 did not regain 
the ability to rise independently at T2, 3 were not assessed at 
the scheduled times, 2 refused to participate in the AM meas-
urements, and 5 were excluded for technical reasons (missing 
signal for one of the sensors due to cable or connector prob-
lems at one of the measurement times). Thus, a final total of 
23 stroke patients was included in the current study. Of these, 
11 were not measured at T1 because they were not able to rise 
from the chair independently at that time (“severe” group). The 
remaining 12 patients are considered the “mild” group. Fig. 2 
presents a flow diagram of participation. Patients with severe 
stroke tended to have worse walking parameters compared 
Fig. 2. Study participants. AM: activity monitor.
 
 
 
50 stroke patients 
37 stroke patients were measured with AM 
 23 included patients  
Mild group 
12 patients 
Able to rise from the  
chair independently at T1 
3 AM measurement times: 
T1, T2 and T3 
Severe group 
11 patients 
Not able to rise from 
the chair at T1 
2 AM measurement times: 
T2 and T3 
- 8 withdrew from the study 
- 3 were not assessed at the 
scheduled time 
- 2 refused to participate in the 
AM measurements 
 
- Only those patients with at 
least two valid AM assessments 
were included: 
-9 did not recover the ability to 
rise from the chair at T2 
- 5 were excluded because of 
technical problems 
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with those with mild stroke, but the differences did not reach 
statistical significance, except for the Sedentary Exponent (dif-
ference 0.052; p = 0.031 with Bonferroni correction).
At T1, 22 patients were measured in the hospital and 1 at 
home. At T2, 21 patients were at home, 1 in a nursing home, 
and another in a rehabilitation centre, whereas at T3 all subjects 
were measured at home. Table I shows the subjects’ demo-
graphics and the disease characteristics of stroke patients at 
baseline (first week post-stroke).
Most parameters were normally distributed (Shapiro-Wilk 
test). The variables “mean duration of walking bout” and 
“walking coefficient of variation” were based on a log-normal 
distribution.
Descriptives of the amount, distribution, quality and speed 
of walking are shown in Table II. Mean and standard devia-
tion are shown for primary and secondary outcome measures 
at the first week (n = 12), 12th week (n = 23) and 1 year after 
stroke (n = 23).
Results from linear mixed model analysis are shown in Table 
III and Fig. 3. An overall time effect was found for time walk-
ing, upright and sedentary time, with largest and significant 
changes between T1 and T2. No recovery was found for the 
Table I. Summary of subjects’ demographics (stroke patients and healthy controls) and clinical information related to stroke patients at baseline (first 
week post-stroke)
Mild stroke groupa
(n = 12)
Severe stroke groupa
(n = 11)
Total stroke group 
(n = 23)
Healthy group
(n = 20)
Age, years, mean (SD) 64.33 (10.10) 51.36 (11.82) 58.13 (12.58) 55.35 (12.70)
Sex, F/M, n 3/9 1/10 4/19 9/11
Type of stroke, n
Haemorrhagic 3 6 9
Ischaemic 9 5 14
Paretic side, n
Right 6 6 12
Left 6 5 11
Stroke localization, n
Basal ganglia 2 4 6
Anterior cerebral artery 2 1 3
Middle cerebral artery 1 2 3
Unspecified 7 4 11
FIM, median ± IQR 109.5 ± 15 57 ± 63 93 ± 56
MAS, median ± IQR 42 ± 10.5 20 ± 31 35 ±25
a”Mild group”: stroke patients who were able to rise independently from the chair at T1 (1st week); “Severe group”: stroke patients who were not able 
to rise independently from the chair at T1.
FIM: Functional Independence Measure; IQR: interquartile range; MAS: Motor Assessment Scale; SD: standard deviation.
Table II. Descriptive data for quantity, distribution, quality and gait speed outcomes
Dimensions Outcomes
T1 (1st week)
n = 12
Mean (SD)
T2 (12th week)
n = 23
Mean (SD)
T3 (48th week)
n = 23
Mean (SD)
Amount Time walking, % 3.65 (2.61) 12.48 (11.11) 11.84 (10.09)
Time upright, % 12.77 (9.75) 27.34 (15.49) 26.78 (13.59)
Time sitting, % 59.87 (16.74) 53.22 (22.05) 52.40 (22.80) 
Time lying, % 24.76 (14.36) 16.83 (18.25) 17.61 (19.38)
Sedentary time,% 83.77 (11.30) 69.92 (15.55) 70.02 (14.36)
Distribution Mean duration of walking bout (s) 14.97 (5.47) 16.46 (11.27) 15.20 (7.13)
Number of walking bouts 47.67 (33.97) 104.83 (61.16) 112.91 (69.51)
Walking coefficient of variation 0.05 (0.01) 0.05 (0.02) 0.06 (0.02)
Sedentary exponent 1.27 (0.07) 1.28 (0.07) 1.27 (0.06)
Quality Step regularity lon (LAd1) 0.60 (0.19) 0.61 (0.23) 0.67 (0.23)
Stride regularity lon (LAd2) 0.53 (0.19) 0.60 (0.24) 0.65 (0.22)
Gait symmetry lon (LAd1/LAd2) 1.12 (0.13) 1.03 (0.17) 1.02 (0.19)
Step regularity tra (TAd1) –0.64 (0.20) –0.60 (0.17) –0.64 (0.15)
Stride regularity tra (TAd2) 0.71 (0.16) 0.68 (0.14) 0.71 (0.14)
Gait symmetry tra (TAd1/TAd2) –0.87 (0.20) –0.88 (0.15) –0.83 (0.32)
Step time ratio (PST/NPST) 1.00 (0.08) 1.17 (0.37) 1.15 (0.39)
Gait speed 5 MWT, m/s 0.76 (0.21) 0.95 (0.31) 1.01 (0.27)
Bod.Mot.Wal., g 0.12 (0.03) 0.16 (0.06) 0.17 (0.05)
lon: derived from the longitudinal trunk sensor; LAd1: longitudinal autocorrelation coefficient at first dominant period; LAd2: longitudinal 
autocorrelation coefficient at second dominant period; tra: derived from the transversal trunk sensor; TAd1: transversal autocorrelation coefficient 
at first dominant period; Td2: transversal autocorrelation coefficient at second dominant period; PST: paretic step-time; NPST: non-paretic step-
time; 5MWT: 5-m walking test; Bod.Mot.Wal.: body motility signal during walking; g: 1 g = 9.8 m/s. 
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Table III. Linear mixed model analysis of change over time for each outcome, presenting estimated values (mean±standard error) for 23 patients at 
the 3 measurement times (T1, T2 and T3), overall p-values and post-hoc comparisons (without Bonferroni correction) between assessment moments: 
T1 and T2 (P 1–2), and T2 and T3 (P 2–3) and T1 and T3 (P 1–3)
Outcomes
T1 (1st week)
Mean ± SE
T2 (12th week)
Mean ± SE
T3 (48th week)
Mean ± SE P overall P 1–2 P 2–3 P 1–3
Amount
Time walking, % 3.33 ± 2.19 12.45 ± 2.37 11.82 ± 2.14 0.03 0.01 0.71 0.01
Time upright, % 8.35 ± 3.65 27.14 ± 3.15 26.58 ± 2.69 < 0.01 < 0.01 0.87 < 0.01
Time sitting, % 60.69 ± 7.10 53.28 ± 4.67 52.47 ± 4.85 0.65 0.44 0.85 0.37
Time lying, % 26.78 ± 5.94 16.92 ± 3.87 17.70 ± 4.07 0.42 0.21 0.82 0.26
Sedentary time, % 87.37 ± 4.27 70.07 ± 3.19 70.17 ± 2.97 0.01 < 0.01 0.98 0.01
Distribution
Mean duration walking bouts (s) 13.98 ± 2.10 16.46 ± 2.37 15.20 ± 1.51 0.59 0.54 0.30 0.70
Number of walking bouts 26.29 ± 12.85 103.87 ± 12.28 111.95 ± 13.66 < 0.001 < 0.01 0.58 < 0.001
Walking coefficient of variation 0.06 ± 0.01 0.06 ± 0.00 0.06 ± 0.00 0.90 0.99 0.73 0.74
Sedentary exponent 1.24 ± 0.02 1.28 ± 0.01 1.28 ± 0.01 0.40 0.20 0.70 0.21
Quality
Step regularity lon (LAd1) 0.56 ± 0.06 0.60 ± 0.05 0.66 ± 0.05 0.08 0.51 0.12 0.08
Gait symmetry lon (LAd1/LAd2) 1.12 ± 0.04 1.03 ± 0.04 1.02 ± 0.04 0.12 0.10 0.68 0.048
Step regularity tra(TAd1) –0.60 ± 0.06 –0.60 ± 0.03 –0.63 ± 0.03 0.52 0.94 0.27 0.64
Stride regularity lon (LAd2) 0.48 ± 0.06 0.59 ± 0.05 0.64 ± 0.05 0.09 0.14 0.28 0.04
Stride regularity tra (TAd2) 0.68 ± 0.05 0.68 ± 0.03 0.71 ± 0.03 0.66 0.97 0.41 0.57
Gait symmetry tra (TAd1/TAd2) –0.82 ± 0.07 –0.88 ± 0.03 –0.83 ± 0.07 0.43 0.45 0.44 0.95
Step-time ratio 1.14 ± 0.08 1.20 ± 0.08 1.17 ± 0.08 0.76 0.57 0.60 0.72
Gait speed
Body motility walking, g 0.13 ± 0.02 0.16 ± 0.01 0.17 ± 0.01 0.10 0.14 0.59 0.049
5MWT, m/s 0.69 ± 0.08 0.94 ± 0.07 1.00 ± 0.06 < 0.01 0.02 0.11 < 0.01
SE; standard error; lon, derived from the longitudinal trunk sensor; LAd1, longitudinal autocorrelation coefficient at first dominant period; tra, derived 
from the transversal trunk sensor; TAd1, transversal autocorrelation coefficient at first dominant period; LAd2, longitudinal autocorrelation coefficient 
at second dominant period; TAd2, transversal autocorrelation coefficient at second dominant period; g, 1 g = 9.8 m/s; 5 MWT, 5-m walking test.
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Fig. 3. Results of linear mixed model analysis at T1, 1 week after stroke onset; T2, 3 
months after stroke; T3, 1 year after stroke, and comparison with the healthy control 
group. (A) Time walking, (B) time upright, (C) mean duration of walking bouts, (D) 
number of walking bouts, (E) step regularity longitudinal, (F) gait symmetry longitudinal, 
and (G) gait speed. *Significant differences between different measurement times (stroke 
group) and between stroke and healthy group at T3 (p < 0.05). Error bars at the top of 
each column (T1, T2, T3 and Healthy) represent ± standard error.
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last 9 months of the follow-up (T3 vs T2). Similar, but not 
significant, patterns were found for time sitting and lying. 
The number of walking bouts and walking speed (5-m walk-
ing test) showed an overall effect of measurement time with a 
statistically significant change from T1 to T2. Mean duration 
of walking bouts and the secondary outcomes of distribution 
did not change significantly throughout the study period. 
Quality outcomes and body motility showed borderline over-
all time effects, with significant post-hoc differences (without 
Bonferroni correction) between T1 and T3 for gait symmetry 
longitudinal, stride regularity longitudinal and body motility. 
However, if we applied a Bonferroni correction and adjusted 
the p-values accordingly, these changes over time were no 
longer significant. All remaining quality outcomes showed 
patterns of improvements, but those were not significant 
throughout the first year post-stroke.
The comparisons for the primary outcomes between patients 
and healthy subjects at T3 are shown in Fig. 3. One year after 
stroke, patients showed an apparently complete recovery on the 
amount outcomes, except for percentage lying (17.61 vs 1.16, 
p < 0.01) and total sedentary time (70.02 vs 59.96, p = 0.02). 
Distribution outcomes were not significantly different between 
healthy and stroke subjects. Step regularity longitudinal and 
gait speed showed significant differences between both groups 
(p < 0.02), but other quality outcomes were not significantly 
different between groups.
Correlation analysis was performed for the primary outcomes 
measures (Table IV). The strongest relationships were found 
between step regularity–gait speed and time walking–gait 
speed and between quantity and distribution outcomes. Re-
lationships were low or moderate for the other parameters. 
DISCUSSION
This study showed different patterns (course over time) and 
different degrees of recovery (level of recovery achieved) 
between several domains of walking behaviour. Recovery of 
amount was large and rapid, reaching levels similar to those 
of the healthy group after 3 months. By contrast, distribution 
outcomes showed no significant improvements throughout the 
year, and data from stroke people were similar to those from 
normal controls at T3. At the same time, the quality and speed 
of walking showed small, but steady, improvement, with lower 
values than for healthy people, even 1 year after stroke onset. 
As stated, primary amount outcomes, number of walking 
bouts and walking speed increased significantly over the first 
3 months, but levelled off during the last 9 months. This pat-
tern of recovery is similar to that found by Kollen et al. (30) 
and Askim et al. (31), who suggested that most pronounced 
improvements in functional outcomes occurred early after 
stroke. In agreement with these results, Jorgensen et al. (32) 
found that recovery of walking function occurred in 95% of pa-
tients within the first 11 weeks after stroke. This improvement 
may be due to the natural recovery processes, compensation 
(33), but will also be affected by environmental and personal 
factors, such as lifestyle and motivation. For example, in our 
study, most patients were hospitalized at T1, whereas they were 
mostly at home after 3 and 12 months. The low percentages 
walking and upright might be the direct result of the stroke, 
but also due to several conditions in the hospital, which do not 
stimulate patients to be active (34).
Whereas the volume of movement behaviour immediately 
post-stroke and its pattern of recovery might be explainable, 
the fact that these parameters at the 3rd and the 12th month 
are not different from those of the healthy group was less 
expected. This finding is also in conflict with other studies; 
e.g. Michael et al. (35) found that mean ambulatory profiles 
were extremely low in patients more than 6 months after stroke 
onset. A factor that might explain this is the duration of the 
measurement period. In the present study, for both healthy and 
stroke groups the time-frame analysed was from 10.00 h to 
18.00 h. The comparison group was, at least partly, a working 
population, with (low) activity levels steered by occupation. 
In addition, it is possible that the observed overall recovery 
was the current clinical practice in the Netherlands, with all 
its clinical diversity, and in other locations different medical 
care might have affected the studied outcomes. 
Deeper insight into patterns of behaviour is provided by 
the distribution analysis. On the one hand, in our distribution 
Table IV. Correlations coefficients (p-value) between primary outcome 
measures for each domain of walking behaviour
Amount
Time walking 
(%)
Time upright 
(%)
Distribution
Mean duration of walking bout 0.76 (< 0.001) 0.45 (< 0.001)
Number walking bouts 0.50 (< 0.001) 0.74 (< 0.001)
Quality
Step regularity lon (LAd1) 0.50 (< 0.001) 0.39 (< 0.01)
Gait symmetry lon (LAd1/LAd2) –0.28 (0.03) –0.17 (0.20)
Gait speed
Bod.Mot.Wal. (g) 0.74 (< 0.001) 0.54 (< 0.001)
Distribution
Mean duration 
of walking bout
Number 
walking bouts
Quality
Step regularity lon (LAd1) 0.32 (0.02) 0.28 (0.04)
Gait symmetry lon (LAd1/LAd2) –0.18 (0.18) –0.18 (0.19)
Gait speed
Bod.Mot.Wal. (g) 0.53 (< 0.001) 0.30 (0.02)
Quality
Step regularity 
lon (LAd1)
Gait symmetry 
lon (LAd1/
LAd2)
Gait speed
Bod.Mot.Wal. (g) 0.65 (< 0.001) –0.33 (0.01)
lon: derived from the longitudinal trunk sensor; LAd1, longitudinal 
autocorrelation coefficient at first dominant period; LAd2, longitudinal 
autocorrelation coefficient at second dominant period; Bod. Mot. Wal., 
body motility signal during walking; g, 1g = 9.8 m/s.
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results, neither walking parameters (mean duration of walk-
ing bouts and walking coefficient of variation) nor sedentary 
exponent changed during the first year after stroke. Only the 
number of walking bouts improved significantly from T1 to 
T2. On the other hand, regarding the amount dimension, both 
total time walking and sedentary time experienced significant 
changes from T1 to T2, and levelling off from T2 to T3. Thus, 
our results indicate that this cohort became more active by 
increasing the number of active periods and not by increasing 
the length of these active periods. 
As far as the recovery of gait pattern is concerned, although 
changes in quality outcomes were rather small between con-
secutive measurement times, all showed a tendency to steadily 
improve from T1 to T3. However, some significant differences 
were found for step regularity (LAd1) and gait speed in the 
comparison between stroke patients and healthy controls 1 year 
after stroke. That is in line with some authors (36) who described 
that gait asymmetry persists in the long-term post-stroke.
One striking finding of the current research was the weak 
correlation between the amount of walking and gait quality 
outcomes expressed both by the low correlation coefficients 
and by the different recovery patterns, with amount parameters 
recovering faster and to a more normal degree than quality. 
This divergence between quantity and quality may have nega-
tive clinical consequences. Firstly, it might be that the normal 
amount of walking with a non-normal quality results in a risk 
of overuse (e.g. of the non-paretic leg or the trunk). This might 
lead to increased energy cost, more fatigue, and an increased 
chance of musculoskeletal injury of the non-paretic leg in 
the long-term. This may cause patients to restrict their walk-
ing activity, leading to a decline in mobility post-stroke (3). 
Secondly, considering that stroke patients are walking more 
without sufficient recovery of gait quality, their fall risk might 
be increased (37). Further studies are necessary to determine 
which gait quality parameters make people with stroke more 
prone to fall. 
Study limitations
This study has some limitations. Firstly, the sample was small 
and heterogeneous. Small differences between the groups may 
not have reached statistical significance because of the small 
sample size.
Related to distribution outcomes, the 8-h 1-day assessment 
could be considered short (38), but performing measurements 
over more days with the cabled version of the accelerometer 
was not practically feasible. To increase accuracy, further work 
with more sample days is needed. 
With regard to the lack of expected significant differences 
between controls and patients, it is possible that measures in 
the present study are not sensitive enough to detect differences; 
further research is needed. 
Finally, concerning the correlation analysis, no corrections 
were made for multiple testing, because the power to detect 
significant differences would have become too low. Hence our 
results must be interpreted with care. 
Conclusion
The results of this study show that, for this cohort, the recovery of 
the amount of walking reached levels close to that of age-matched 
healthy levels. However, the pattern of walking was still altered 
and sedentary behaviour unchanged, showing that recovery of 
the amount of walking did not necessarily translate into change in 
behaviour and improved walking quality. This suggests that these 
aspects of walking represent different constructs. Therefore, these 
different constructs should be included in gait studies in order 
to enhance our understanding of gait performance in daily life.
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